Zobrazeno 1 - 2
of 2
pro vyhledávání: '"CA Chan-Navarro"'
Autor:
Chris Twelves, D Maraninchi, Joseph McKendrick, Robert C. F. Leonard, AS Bexon, N Barak-Wigler, CA Chan-Navarro, S Vukelja, Joyce A. O'Shaughnessy, V Gorbounova, WG Harker
Publikováno v:
Annals of Oncology. 17:1379-1385
Background: In a phase III trial, 3-weekly capecitabine (1250 mg/m 2 twice daily days 1–14) plus docetaxel (75 mg/m 2 day 1) demonstrated significantly superior overall survival to 3-weekly docetaxel (100 mg/m 2 day 1). We report a retrospective an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b1df4d79bca625dcd755568b607759
https://doi.org/10.1093/annonc/mdl134
https://doi.org/10.1093/annonc/mdl134
Autor:
Leonard R; Southwest Wales Cancer Institute, Singleton Hospital, Swansea, UK. robert.leonard@swansea-tr.wales.nhs.uk, O'Shaughnessy J, Vukelja S, Gorbounova V, Chan-Navarro CA, Maraninchi D, Barak-Wigler N, McKendrick JJ, Harker WG, Bexon AS, Twelves C
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2006 Sep; Vol. 17 (9), pp. 1379-85.